PACIFIC EDGE LIMITED

ASX:PEBPharmaceuticals, Biotechnology & Life Sciences

1.24B shares on issueASX (delayed) · snapshot 11 Sept 20261.29B fully diluted+3.7% if every option and right converts$0.20price · delayed$254.6Mmarket cap · indicative

Today’s holders own 96.5% of what they think they own, once every option and right converts.

Moderate

Dilution risk

Share count grew 53% in 24 months; 2 cash raises in 24 months

Absolute levels — not a ranking against other companies.

Cash runwayno data — not a quarterly (4C/5B) cash filer

Share-count growth (24m)53.0%

Raise cadence (24m)2 cash raises

Options & rights overhang3.7% of shares

In-the-money supplyno data — no exercise price on record

Pending proposed issuesnone

PACIFIC EDGE LIMITED's ordinary share count grew 53.0% between July 2024 and August 2026, to 1.24B shares. The company raised capital twice in the past 24 months for total disclosed proceeds of A$56.8M, most recently a A$36.1M placement and retail offer in May 2026. Options and rights on issue could convert into 46M new shares, equal to 3.7% of the current share count. An expiry date for these options is not on record, and none are currently in the money. The company has no proposed securities issues pending. As no current quarterly cash report is on record, a cash balance and funding-runway figure are not disclosed.

AI-generated summary of this page's cited filings · updated 1 Sept 2026

Get told when this changes

Set up alerts

Daily email alerts cover risk-level moves, new raises, pending proposed issues and option expiries for the companies you follow.

3.7%

Options & rights overhang

—

In-the-money supply · no stated strikes

Raises · last 12 months

—

Cash cover · not a quarterly filer

Shares on issue — last 2 years

Ordinary shares on issue

Weekly counts from ASX records. Dots mark cash capital raises. Latest count 1.24B per ASX (delayed) (snapshot 11 Sept 2026).

Cash runway

Not a quarterly cash filer. This company does not lodge Appendix 4C/5B quarterly cash reports, so cash runway does not apply.

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

Date	Form	Security	On issue, per this filing	Source
26 Aug 2026	2A · quoted issue	PEB : ORDINARY FULLY PAID FOREIGN EXEMPT NZX	1.24B	Appendix 2A
8 July 2026	3G · unquoted	PEB : ORDINARY FULLY PAID FOREIGN EXEMPT NZX	1.24B	Appendix 3G
4 June 2026	2A · quoted issue	PEB : ORDINARY FULLY PAID FOREIGN EXEMPT NZX	1.23B	Appendix 2A
4 June 2026	2A · quoted issue	PEB : ORDINARY FULLY PAID FOREIGN EXEMPT NZX	1.17B	Appendix 2A
4 June 2026	2A · quoted issue	PEB : ORDINARY FULLY PAID FOREIGN EXEMPT NZX	1.18B	Appendix 2A

Free account

24 filings on record — Full issuance history

Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).

Free account: 2 full company unlocks every month, no card.

Create free account See plans

Capital raises

2 cash raises in the last 24 months · 1 in the last 12 months

every 10.1 monthsaverage gap between raises

4 monthssince the most recent

11 July 2025 – 13 May 2026first to most recent in this window

$29.6M

Placement + Retail Offer

13 May 2026 COMPLETE

Free account

5 raises on record — Full raise history

Issue price, shares issued, brokers and stated purpose for every raise on record.

Free account: 2 full company unlocks every month, no card.

Create free account See plans

Forward supply

Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.

Free account

Forward supply calendar

Option expiries and proposed issues on one forward timeline, with the securities each could add.

Free account: 2 full company unlocks every month, no card.

Create free account See plans

Placement capacity

How much stock a company can place without asking holders. Listing Rule 7.1 allows 15% of ordinary securities in any 12 months, and every Appendix 3B states how much of it an issue uses.

No Appendix 3B in the last 12 months reports an issue under the 15% placement capacity (as at 2026-09-12).

Free account

Placement capacity — LR 7.1 / 7.1A

The filings behind the figure: every Appendix 3B in the window with what it says was issued under 7.1 and 7.1A, each row linked to its filing, and how many shares are left.

Free account: 2 full company unlocks every month, no card.

Create free account See plans

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

3.7%

Options & rights overhang · of current shares

—

In-the-money supply · no stated strikes

45.7M

Potential new shares

—

Nearest expiry

What a price move would switch on

No option supply on record carries an exercise price to pay, so no share price switches any of it on. All 45.7M of it converts on something else — a hurdle that may never be met, or terms the filing does not price.

Code	Security	Type	Exercise price	Expiry	On issue	Source
PEBAA	Options	Price-triggered	—	—	45.7M	Filing

“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column.

Free account

1 option line on record — In-the-money value & price ladder

What each line is worth in the money today, the price ladder to the next tranche that converts, and the filing description behind every code.

Free account: 2 full company unlocks every month, no card.

Create free account See plans